Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy

• Asıl Yazarlar: Nicolas Kerckhove (Yazar), Marie Selvy (Yazar), Céline Lambert (Yazar), Coralie Gonneau (Yazar), Gabrielle Feydel (Yazar), Caroline Pétorin (Yazar), Agnès Vimal-Baguet (Yazar), Sergey Melnikov (Yazar), Sharif Kullab (Yazar), Mohamed Hebbar (Yazar), Olivier Bouché (Yazar), Florian Slimano (Yazar), Vincent Bourgeois (Yazar), Valérie Lebrun-Ly (Yazar), Frédéric Thuillier (Yazar), Thibault Mazard (Yazar), David Tavan (Yazar), Kheir Eddine Benmammar (Yazar), Brigitte Monange (Yazar), Mohamed Ramdani (Yazar), Denis Péré-Vergé (Yazar), Floriane Huet-Penz (Yazar), Ahmed Bedjaoui (Yazar), Florent Genty (Yazar), Cécile Leyronnas (Yazar), Jérôme Busserolles (Yazar), Sophie Trévis (Yazar), Vincent Pinon (Yazar), Denis Pezet (Yazar), David Balayssac (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in colorectal cancer survivors, a secondary analysis was d...